In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Publisher’s Spotlight: Citeline News And Insights App

Executive Summary

Introducing the all-new Citeline News and Insights app, providing seamless access to all your favorite award-winning publications. Explore the latest articles from Pink Sheet, Scrip, In Vivo, Medtech Insight, Generics Bulletin and HBW Insight, all in one stylish, intuitive and user-friendly platform.

Enjoy a faster, streamlined experience, tailor-made for your mobile device – now available on the App Store and Google Play.

 

Effortlessly switch between publications, customize your home screen, and search for articles across the full suite of Citeline publications. Stay up to date with breaking news notifications and save offline articles for later with the personalized 'my content' feature, ensuring you never miss a beat.

  

This is the new way to experience your news and insights.

 

  • Seamless Experience: The mobile-native app provides streamlined access to all Citeline’s news and insights publications.

  • Swipe and Customize: Effortlessly switch between publications and customize your experience, ensuring you only see what matters most.

  • Detailed Search: Discover the latest insights at your fingertips, searching the latest articles across multiple publications.

  • Anytime, Anywhere: Bookmark articles for later, even offline! Access your saved articles in "My Content" for reading anytime, anywhere.

  • Endless Connectivity: Enjoy a hassle-free experience – once logged in, stay connected even when switching to the browser version of the publication.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

IV148717

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel